Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 489 (LINC00489)
- Target
- LINC00489
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01
Overview
LINC00489 is a long intergenic non-protein coding RNA gene in humans that generates a transcript longer than 200 nucleotides and does not overlap protein-coding regions. Its RNA product belongs to the lincRNA class, which are involved in fine-tuning gene expression, chromatin remodeling, and possibly in enhancer-like functions within gene regulatory networks. While lincRNAs including LINC00489 do not encode proteins, they exert regulatory effects, and emerging evidence implicates aberrant regulation of lincRNAs in cancer and other diseases. However, there are currently no therapeutics that target LINC00489 directly, and its potential as a biomarker or therapeutic target remains under investigation.
- Other names
- LINC00489long intergenic non-protein coding RNA 489
02
Mechanism of action
Not applicable — no drugs target this molecule directly; impact is through regulatory pathways
03
Biological functions
Regulation of gene expressionChromatin remodelingRNA stabilizationPossibly enhancer-associated activity (regulatory RNA)
04
Disease associations
Cancer (aberrant expression of many lincRNAs, including LINC00489 and similar molecules, is associated with cancer, often as part of complex regulatory networks)Other (lncRNAs/lincRNAs are emerging as regulators in diverse diseases, but specific roles for LINC00489 in other diseases have not been established in well-cited databases or literature)
05
Safety considerations
No direct safety concerns reported for targeting LINC00489, as it is not targeted by current therapeutics; however, targeting lincRNAs can have unpredictable effects given their diverse regulatory roles
06
Biomarkers
The role of lincRNAs as biomarkers is an active area of research, especially in cancer diagnostics and prognosis, but specific validated biomarker uses for LINC00489 are not documented as of now
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 489 (LINC00489).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 489 (LINC00489).